Silco Pharmaceuticals Limited (DSE: SILCOPHL)
Bangladesh
· Delayed Price · Currency is BDT 15.70
-0.20 (-1.26%)
At close: Nov 14, 2024
Silco Pharmaceuticals Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2014 |
| Net Income | 42.76 | 69.22 | 84.45 | 84.65 | 83.18 | 162.48 | Upgrade
|
| Depreciation & Amortization | 90.53 | 90.53 | 78.49 | 78.4 | 78.69 | 82.47 | Upgrade
|
| Loss (Gain) From Sale of Investments | -18.56 | -18.56 | -6.48 | -0.42 | - | - | Upgrade
|
| Other Operating Activities | -43.49 | 13.22 | 16.77 | -9.2 | 22.4 | -22.04 | Upgrade
|
| Change in Accounts Receivable | 11.73 | 11.73 | 1.3 | 94.46 | 5 | -100.62 | Upgrade
|
| Change in Inventory | 13.7 | 13.7 | -8.39 | 5.26 | -28.68 | -27.67 | Upgrade
|
| Change in Accounts Payable | -3.26 | -3.26 | -7.3 | -2.7 | 0.68 | 0.4 | Upgrade
|
| Change in Other Net Operating Assets | 3.9 | 3.9 | 10.23 | 6.77 | -14.65 | -14.25 | Upgrade
|
| Operating Cash Flow | 97.3 | 180.48 | 169.08 | 257.21 | 146.61 | 80.77 | Upgrade
|
| Operating Cash Flow Growth | -48.09% | 6.74% | -34.26% | 75.44% | 81.52% | -6.62% | Upgrade
|
| Capital Expenditures | -63.31 | -181.95 | -106.13 | -376.43 | -170.05 | -75.49 | Upgrade
|
| Investment in Securities | 23.72 | 22.71 | -28.81 | 136.17 | -5.95 | -150 | Upgrade
|
| Other Investing Activities | -1.47 | 18.56 | 6.48 | 0.42 | 0 | - | Upgrade
|
| Investing Cash Flow | -41.06 | -140.68 | -128.47 | -239.83 | -176.01 | -225.49 | Upgrade
|
| Long-Term Debt Repaid | - | -4.11 | -3.77 | -3.54 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -4.28 | -4.11 | -3.77 | -3.54 | - | - | Upgrade
|
| Issuance of Common Stock | - | - | - | - | - | 300 | Upgrade
|
| Common Dividends Paid | -19.38 | -31.45 | -62.62 | -62.01 | -18.39 | - | Upgrade
|
| Other Financing Activities | -0.72 | -0.2 | -0.53 | -0.76 | -1.96 | -19.22 | Upgrade
|
| Financing Cash Flow | -24.37 | -35.76 | -66.93 | -66.31 | -20.35 | 280.78 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | 0 | -0 | 0 | - | 0 | Upgrade
|
| Net Cash Flow | 31.86 | 4.05 | -26.31 | -48.94 | -49.75 | 136.06 | Upgrade
|
| Free Cash Flow | 33.99 | -1.47 | 62.95 | -119.22 | -23.45 | 5.28 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | - | -0.68% | Upgrade
|
| Free Cash Flow Margin | 8.06% | -0.32% | 11.25% | -19.83% | -3.20% | 0.57% | Upgrade
|
| Free Cash Flow Per Share | 0.33 | -0.01 | 0.61 | -1.15 | -0.23 | 0.07 | Upgrade
|
| Cash Interest Paid | 0.16 | 0.2 | 0.53 | 0.76 | - | - | Upgrade
|
| Cash Income Tax Paid | 5.02 | 6.99 | 8.27 | 14.95 | 5.32 | 1.35 | Upgrade
|
| Levered Free Cash Flow | 27.34 | -11.67 | 36.24 | -142.51 | -52.35 | -17.62 | Upgrade
|
| Unlevered Free Cash Flow | 27.77 | -11.55 | 36.57 | -142.03 | -52.35 | -17.62 | Upgrade
|
| Change in Net Working Capital | 34.43 | -37.89 | -3.28 | -106.37 | 21.59 | 113.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.